Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis Elena Conesa-Nicolás, María Henar García-Lagunar, Sara Núñez-Bracamonte, María Sergia García-Simón, María Carmen Mira-Sirvent

Use of ustekinumab after other biological therapies in moderate-severe psoriasis: Real long-term data Manuel David Gil-Sierra, Esmeralda Ríos-Sánchez, María del Pilar Briceño-Casado

Risk-sharing agreement based on health outcomes for the treatment of moderate–severe psoriasis with certolizumab pegol Andrés Navarro Ruiz, Fernando Toledo Alberola, Susana Aceituno